Search for: "Sanofi-Aventis"
Results 21 - 40
of 563
Sorted by Relevance
|
Sort by Date
21 Jul 2009, 9:28 pm
By Suresh Pillai -- Judge Denies Attorneys Fees to Sandoz in Dispute with Sanofi-Aventis The U.S. [read post]
12 Sep 2007, 9:48 am
Inc. and sanofi-aventis U.S. [read post]
18 Jul 2007, 8:41 am
Forbes noted: "Sanofi-Aventis has not yet been served with a complaint by Novo and our understanding of Novo's allegation is very preliminary,' a spokesman for Sanofi-Aventis told Thomson Financial. [read post]
25 Jun 2021, 4:15 am
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
11 Apr 2011, 12:57 pm
See Sanofi-Aventis v. [read post]
25 Mar 2011, 8:26 am
However, when asked to pay the bills, sanofi-aventis refused. [read post]
25 Mar 2011, 8:26 am
However, when asked to pay the bills, sanofi-aventis refused. [read post]
8 Oct 2010, 6:49 am
The battle between Sanofi-Aventis and Genzyme is quickly becoming a war of words. [read post]
22 Jul 2012, 6:40 am
Appeal Decision: Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (No 2) [2012] FCAFC 102 (18 July 2012) Appeal from: Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) [2011] FCA 846 See also: Australian Federal Court ‘Evergreens’ ARAVA for Sanofi-Aventis Claim construction – second medical use claims directed to treating specific ailments – Novelty –… [read post]
25 Jun 2021, 4:15 am
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
10 Dec 2013, 10:01 am
Per the EFF, Sanofi-Aventis backed down: “Under terms of Tuesday’s settlement, AcompliaReport.com keeps its domain name, as long as there is a disclaimer stating that the website is not associated with Sanofi-Aventis. [read post]
23 Mar 2006, 10:15 pm
Bristol-Myers Squibb Company and sanofi-aventis announced earlier this week that they have reached a tentative settlement agreement with Apotex Inc. and Apotex Corp. regarding the pending Plavix ® patent infringement lawsuit. [read post]
29 Mar 2017, 5:15 am
The major impetus behind this suit was Sanofi-Aventis and Regeneron’s discovery that Amgen hired litigation counsel to assert the ‘487 patent and is also working on retaining experts. [read post]
17 Jan 2008, 5:30 pm
Ramipril, by Sanofi-Aventis is an angiotensin-converting enzyme (ACE) inhibitor, used to treat hypertension and congestive heart failure. [read post]
15 Feb 2011, 12:36 pm
Sanofi-Aventis is poised to raise its bid for Genzyme to about $74 a share, and a deal could be announced as soon as Wednesday. [read post]
16 Sep 2010, 11:46 am
Genzyme reached an agreement to sell its Genzyme Genetics unit to LabCorp in the midst of buyout talks with Sanofi-Aventis. [read post]
18 Feb 2011, 3:00 am
Aiello led the team advising longtime Weil client Sanofi-Aventis on its $20.1 billion takeover of Genzyme. [read post]
16 Feb 2011, 12:00 am
The deal ends months of haggling after Sanofi-Aventis unsuccessfully sought to acquire Genzyme for $18.5 billion. [read post]
24 Jan 2011, 2:41 am
Sanofi-Aventis has extended its $69-a-share tender offer for all outstanding Genzyme common stock to Feb. 15. [read post]
9 Apr 2012, 4:00 pm
Hospira, Inc., the Federal Circuit upheld the district court’s finding that two of the Orange Book listed patents for Sanofi Aventis’ cancer drug Taxotere are unenforceable for inequitable conduct. [read post]
